|
LIMD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1233999996918E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84320999999654E-05 |
| Normal-vs-Stage2 |
7.983100E-04 |
| Normal-vs-Stage3 |
8.53899995156837E-09 |
| Normal-vs-Stage4 |
3.78539999346117E-09 |
| Stage1-vs-Stage2 |
9.193000E-01 |
| Stage1-vs-Stage3 |
8.780500E-03 |
| Stage1-vs-Stage4 |
2.696600E-03 |
| Stage2-vs-Stage3 |
9.893800E-02 |
| Stage2-vs-Stage4 |
4.729600E-02 |
| Stage3-vs-Stage4 |
5.992200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.52709999884971E-08 |
| Normal-vs-AfricanAmerican |
2.427900E-02 |
| Normal-vs-Asian |
1.88949999999632E-05 |
| Caucasian-vs-AfricanAmerican |
2.995200E-01 |
| Caucasian-vs-Asian |
7.847200E-01 |
| AfricanAmerican-vs-Asian |
3.014200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03949999996633E-06 |
| Normal-vs-Female |
2.79899999955369E-07 |
| Male-vs-Female |
8.917400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.15299999994922E-06 |
| Normal-vs-Age(41-60Yrs) |
6.3539999994866E-07 |
| Normal-vs-Age(61-80Yrs) |
8.01520000037748E-07 |
| Normal-vs-Age(81-100Yrs) |
1.493550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.124600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.680000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.901200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.895400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.400600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.27860000365132E-08 |
| Classical-VS-Follicular |
7.736800E-01 |
| Classical-VS-Other |
9.452400E-01 |
| Classical-VS-Normal |
1.20439999995448E-06 |
| Tall-VS-Follicular |
2.63430000002618E-06 |
| Tall-VS-Other |
6.325900E-02 |
| Tall-VS-Normal |
4.76285677564192E-14 |
| Follicular-VS-Other |
9.733400E-01 |
| Follicular-VS-Normal |
5.227400E-04 |
| Other-VS-Normal |
5.957800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70453999999154E-05 |
| Normal-vs-N1 |
1.56240000048768E-07 |
| N0-vs-N1 |
6.657900E-02 |
|
|
